GLP-1 Drugs May Ease Psoriasis in Some Patients, Study Finds
A new study finds GLP-1 receptor agonists improved psoriasis in some patients, reinforcing the link between metabolic health and skin inflammation.
Stories
Stories
A new study finds GLP-1 receptor agonists improved psoriasis in some patients, reinforcing the link between metabolic health and skin inflammation.
Palvella Therapeutics presented clinical and claims data at a dermatology conference, pairing trial results with real-world analy…
Kyung Hee University researchers report a link between fine particulate matter exposure and atopic dermatitis, adding Korean data…
An epigenomic ctDNA assay reading methylation signatures predicts recurrence in resected melanoma, potentially guiding adjuvant t…
Fall Clinical Derm 2026 experts say JAK inhibitors should move earlier in AD and vitiligo care, before disease becomes chronic an…
A rare, 'debilitating' cancer went undiagnosed in Dunedin, RNZ reports, prompting public calls for better dermatology services in…
A Journal of Investigative Dermatology study published October 9, 2026 maps how Wnt/β-catenin pathway components sustain pre–basa…
A Dermatology Times commentary argues that pre-therapy expectation counseling in hidradenitis suppurativa determines adherence an…
The science says no: sunscreen does not cause cancer, and beef tallow offers no UV protection, News24 reports in rebuttal of vira…
Lab-grown human skin with blood vessels and working immune cells reported; the construct could sharpen disease modeling and drug…